Sign Up Today and Learn More About ENYO Pharma Stock
Invest in or calculate the value of your shares in ENYO Pharma or other pre-IPO companies through EquityZen's platform.
ENYO Pharma Stock (ENPH)
ENYO Pharma is a biopharmaceutical company based in Lyon, France.
About ENYO Pharma Stock
Founded
2014
Industries
Science and Engineering, Health Care, Biotechnology
ENYO Pharma Press Mentions
Stay in the know about the latest news on ENYO Pharma
French Tech Funding Wire June 13: Knave, Wandercraft, Look Up Space & More!
frenchtechjournal • Jun 17, 2025
ENYO Pharma Announces Completion of Series C Financing With Vesalius Biocapital and Continued Progress of Its ALPESTRIA-1 Clinical Phase 2 Study in Alport Syndrome Patients
biospace • Jun 12, 2025
ENYO Pharma Announces Completion of Series C Financing With Vesalius Biocapital and Continued Progress of Its ALPESTRIA-1 Clinical Phase 2 Study in Alport Syndrome Patients
businesswire • Jun 12, 2025
Pushing biotech forward in France: 18 companies to know about
labiotech • Jun 11, 2025
L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1- …
patents • May 04, 2025
ENYO Pharma Management
Leadership team at ENYO Pharma
Founder, President and CEO
Jacky Vonderscher
Co-Founder and Head of Drug Discovery Platform
Benoit Chassey
Join now and verify your accreditation status to gain access to:
- ENYO Pharma Current Valuation
- ENYO Pharma Stock Price
- ENYO Pharma Management
- Available deals in ENYO Pharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- ENYO Pharma Cap Table and Funding History by Share Class and Liquidity Preferences
- ENYO Pharma Revenue and Financials
- ENYO Pharma Highlights
- ENYO Pharma Business Model
- ENYO Pharma Risk Factors
- ENYO Pharma Research Report from SACRA Research
Trading ENYO Pharma Stock
How to invest in ENYO Pharma stock?
Accredited investors can buy pre-IPO stock in companies like ENYO Pharma through EquityZen funds. These investments are made available by existing ENYO Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ENYO Pharma stock?
Shareholders can sell their ENYO Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
